心脏中的干细胞治疗:生物材料是关键途径。
Stem cell therapy in the heart: Biomaterials as a key route.
机构信息
Department of Stem Cells and Regenerative Medicine, Royesh Stem Cell Biotechnology Institute, Mashhad, Iran; Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
出版信息
Tissue Cell. 2021 Aug;71:101504. doi: 10.1016/j.tice.2021.101504. Epub 2021 Feb 5.
Cardiovascular diseases are one of the main concerns, nowadays causing a high rate of mortality in the world. The majority of conventional treatment protects the heart from failure progression. As a novel therapeutic way, Regenerative medicine in the heart includes cellular and noncellular approaches. Despite the irrefutable privileges of noncellular aspects such as administration of exosomes, utilizing of miRNAs, and growth factors, they cannot reverse necrotic or ischemic myocardium, hence recruiting of stem cells to help regenerative therapy in the heart seems indispensable. Stem cell lineages are varied and divided into two main groups namely pluripotent and adult stem cells. Not only has each of which own regenerative capacity, benefits, and drawbacks, but their turnover also close correlates with the target organ and/or tissue as well as the stage and level of failure. In addition to inefficient tissue integration due to the defects in delivering methods and poor retention of transplanted cells, the complexity of the heart and its movement also make more rigorous the repair process. Hence, utilizing biomaterials can make a key route to tackle such obstacles. In this review, we evaluate some natural products which can help stem cells in regenerative medicine of the cardiovascular system.
心血管疾病是当今世界主要关注的问题之一,导致高死亡率。大多数传统治疗方法都能保护心脏免受衰竭进展的影响。作为一种新的治疗方法,心脏的再生医学包括细胞和非细胞方法。尽管非细胞方法如外泌体的给药、miRNA 的利用和生长因子具有不可否认的优势,但它们不能逆转坏死或缺血性心肌,因此招募干细胞来帮助心脏的再生治疗似乎是必不可少的。干细胞谱系多种多样,分为两类:多能干细胞和成体干细胞。不仅每种细胞都有自己的再生能力、益处和缺点,而且它们的更替也与目标器官和/或组织以及衰竭的阶段和程度密切相关。除了由于输送方法的缺陷和移植细胞的保留率低导致的组织整合效率低下外,心脏的复杂性及其运动也使修复过程更加严格。因此,利用生物材料可以成为解决这些障碍的关键途径。在这篇综述中,我们评估了一些有助于心血管系统再生医学中干细胞的天然产物。